Posts by Team VIVA!

Australia’s youth mental illness rate continuing to rise

The number of Australians exhibiting symptoms of a serious psychological issue between the age of 15 to 19 has risen by 4.1 per cent in six years, according to new Mission Australia data. Speaking with the Adelaide Advertiser [July 15, 2017], Catherine Yeomans, Mission Australia CEO, said the outcome of the analysis was concerning. “We’re…

Read More

VIVA! Communications celebrates 15th birthday

Yesterday (July 20, 2017), leading Australian health + wellness PR agency, VIVA! Communications celebrated its 15th birthday, armed with news of completing a record financial year, reinforcing the agency’s commitment to excellence and innovation in the healthcare arena. Established in 2002, by Principal, Fellow of the Public Relations Institute of Australia (PRIA) and healthcare PR…

Read More

Australians with asthma urged to exercise vigilance this winter

The National Asthma Council Australia has issued a warning to Australians living with asthma, urging them to protect their health and to be prepared as the cold and flu season kicks in. According to the Council, around 40,000 Australians are hospitalised and 400 die from asthma each year, with winter being a particularly difficult season…

Read More

A potential vaccine for cancer: new data

After nearly half a century of trying to identify a vaccine that might wipe out cancers, similarly to the way vaccine targets influenza or pneumococcal pneumonia, scientists might have made a breakthrough in this arena. According to an article published in The Australian (July 7, 2017), scientists from a German biotechnology company, Biontech, as well as…

Read More

Apotex launches Oviit a new range of vitamins and minerals

Apotex announced the launch of its new premium value, Pharmacy Only range of vitamin and mineral supplements (VMS), Oviit today (July 3, 2017). Expansion into this high growth VMS category signals further diversification of Apotex’s over-the-counter (OTC) portfolio, and a strategy for the generic drug manufacturer to restore value to the VMS category for pharmacy.…

Read More